Health Insurance Fund of Australia has become the first Australian health fund to publicly declare support for medicinal cannabis treatments and provide members with rebates on products.

HIF has formed a strategic partnership with medicinal cannabis manufacturer Little Green Pharma to support improved access and research into medicinal cannabis as a treatment option for patients.

Justin James, CEO of HIF, told Gareth Parker supporting medicinal cannabis aligned with HIF’s goals of providing new, alternative treatment choices to its members.

HIF has confirmed it will pay rebates for medicinal cannabis across all but one of its Extras policies with eligible members receiving up to $105 back per script – a first for the health fund sector.

Download this podcast here